Suboptimal Weight Affects Survival in Cervical Cancer
|
By HospiMedica International staff writers Posted on 05 May 2016 |
|
Both overweight and underweight women with cervical cancer did not live as long as their normal-weight counterparts, according to a new study.
Researchers at the University of Cincinnati (OH, USA) and the University of North Carolina (UNC; Chapel Hill, USA) conducted a retrospective cohort study of 623 women with cervical cancer treated from July 2000 to March 2013, classifying the women according to their body mass index (BMI). In all, 4% of the women were underweight, 30% were normal weight, and 66% were overweight or obese. The primary outcome was overall survival; secondary outcomes included stage, histopathology, disease-specific survival (DSS), and recurrence free survival (RFS).
The results showed that the median overall survival time in overweight or obese women was six months shorter than in women of normal weight (22 versus 28 months); for underweight women, median overall survival time was cut in half (14 versus 28 months). There was no difference in age, stage at presentation, grade, or histology between weight categories. After controlling for prognostic factors, underweight and overweight/obese patients had worse median RFS than normal weight patients. The study was published on April 14, 2016, in in Gynecologic Oncology.
“In understanding the effect of BMI on cervical cancer outcomes, it is important to recognize that both extremes of weight appear to negatively impact survival. A potential unifying hypothesis connecting both extremes of weight to poor cancer prognosis is chronic systemic inflammation,” wrote lead author Leslie Clark, MD, of UNC, and colleagues. “Both patients with cancer cachexia/sarcopenia and overweight/obese patients are in a heightened inflammatory state, which may lead to increased cell proliferation and inhibition of apoptosis.”
"However, this is likely not the only mechanism of poor outcomes. Co-morbid medical conditions might account for some of the differences in survival, particularly in morbidly obese patients,” concluded the authors. “Providers should optimize weight in underweight and overweight/obese patients to attempt to improve outcomes in these women. Interventions that target nutritional counseling and physical activity should be explored in these populations.”
Related Links:
University of Cincinnati
University of North Carolina
Researchers at the University of Cincinnati (OH, USA) and the University of North Carolina (UNC; Chapel Hill, USA) conducted a retrospective cohort study of 623 women with cervical cancer treated from July 2000 to March 2013, classifying the women according to their body mass index (BMI). In all, 4% of the women were underweight, 30% were normal weight, and 66% were overweight or obese. The primary outcome was overall survival; secondary outcomes included stage, histopathology, disease-specific survival (DSS), and recurrence free survival (RFS).
The results showed that the median overall survival time in overweight or obese women was six months shorter than in women of normal weight (22 versus 28 months); for underweight women, median overall survival time was cut in half (14 versus 28 months). There was no difference in age, stage at presentation, grade, or histology between weight categories. After controlling for prognostic factors, underweight and overweight/obese patients had worse median RFS than normal weight patients. The study was published on April 14, 2016, in in Gynecologic Oncology.
“In understanding the effect of BMI on cervical cancer outcomes, it is important to recognize that both extremes of weight appear to negatively impact survival. A potential unifying hypothesis connecting both extremes of weight to poor cancer prognosis is chronic systemic inflammation,” wrote lead author Leslie Clark, MD, of UNC, and colleagues. “Both patients with cancer cachexia/sarcopenia and overweight/obese patients are in a heightened inflammatory state, which may lead to increased cell proliferation and inhibition of apoptosis.”
"However, this is likely not the only mechanism of poor outcomes. Co-morbid medical conditions might account for some of the differences in survival, particularly in morbidly obese patients,” concluded the authors. “Providers should optimize weight in underweight and overweight/obese patients to attempt to improve outcomes in these women. Interventions that target nutritional counseling and physical activity should be explored in these populations.”
Related Links:
University of Cincinnati
University of North Carolina
Gold Member
12-Channel ECG
CM1200B
Ureteral Dilatation Balloon
Dornier Equinox
Ultrasound Needle Guidance System
SonoSite L25
Latest Patient Care News
- Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care
- VR Training Tool Combats Contamination of Portable Medical Equipment
- Portable Biosensor Platform to Reduce Hospital-Acquired Infections
- First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds
- Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization
- Game-Changing Innovation in Surgical Instrument Sterilization Significantly Improves OR Throughput
- Next Gen ICU Bed to Help Address Complex Critical Care Needs
- Groundbreaking AI-Powered UV-C Disinfection Technology Redefines Infection Control Landscape
- Clean Hospitals Can Reduce Antibiotic Resistance, Save Lives
- Smart Hospital Beds Improve Accuracy of Medical Diagnosis
- New Fast Endoscope Drying System Improves Productivity and Traceability
- World’s First Automated Endoscope Cleaner Fights Antimicrobial Resistance
- Portable High-Capacity Digital Stretcher Scales Provide Precision Weighing for Patients in ER
- Portable Clinical Scale with Remote Indicator Allows for Flexible Patient Weighing Use
- Innovative and Highly Customizable Medical Carts Offer Unlimited Configuration Possibilities
- Biomolecular Wound Healing Film Adheres to Sensitive Tissue and Releases Active Ingredients
Channels
Critical Care
view channel
Wearable Devices Could Revolutionize Pregnancy Monitoring and Detect Abnormalities
Pregnancy complications such as miscarriage and preterm birth remain major risks to maternal and child health, especially in the United States, where more than 2 million women live in maternal care deserts.... Read more
AI Model Identifies AF Patients Requiring Blood Thinners to Prevent Stroke
Atrial fibrillation (AF) is the most common abnormal heart rhythm, affecting around 59 million people globally. It increases stroke risk because quivering in the upper heart chambers allows blood clots... Read more
Surgical Techniques
view channel
Novel Method Uses Interstitial Fluid Flow to Predict Where Brain Tumor Can Grow Next
Glioblastoma is one of the most aggressive brain cancers, with patients surviving on average only 15 months after diagnosis. Surgery and radiation can temporarily control the tumor, but the disease almost... Read more
World’s First Custom Anterior Cervical Spine Surgery Performed Using Personalized Implant
Anterior cervical fusion has been performed since the 1950s and is one of the most common spine procedures. Traditional implants are designed as one-size-fits-all, which can affect spinal alignment, healing,... Read more
Health IT
view channel
Printable Molecule-Selective Nanoparticles Enable Mass Production of Wearable Biosensors
The future of medicine is likely to focus on the personalization of healthcare—understanding exactly what an individual requires and delivering the appropriate combination of nutrients, metabolites, and... Read more
Business
view channel
Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies
Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
B. Braun Acquires Digital Microsurgery Company True Digital Surgery
The high-end microsurgery market in neurosurgery, spine, and ENT is undergoing a significant transformation. Traditional analog microscopes are giving way to digital exoscopes, which provide improved visualization,... Read more
CMEF 2025 to Promote Holistic and High-Quality Development of Medical and Health Industry
The 92nd China International Medical Equipment Fair (CMEF 2025) Autumn Exhibition is scheduled to be held from September 26 to 29 at the China Import and Export Fair Complex (Canton Fair Complex) in Guangzhou.... Read more